1229 related articles for article (PubMed ID: 26369473)
1. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.
Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Nanni G; Castagneto M; Bornstein S; Rubino F
Lancet; 2015 Sep; 386(9997):964-73. PubMed ID: 26369473
[TBL] [Abstract][Full Text] [Related]
2. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial.
Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Capristo E; Chamseddine G; Bornstein SR; Rubino F
Lancet; 2021 Jan; 397(10271):293-304. PubMed ID: 33485454
[TBL] [Abstract][Full Text] [Related]
3. Bariatric surgery versus conventional medical therapy for type 2 diabetes.
Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Leccesi L; Nanni G; Pomp A; Castagneto M; Ghirlanda G; Rubino F
N Engl J Med; 2012 Apr; 366(17):1577-85. PubMed ID: 22449317
[TBL] [Abstract][Full Text] [Related]
4. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial.
Ikramuddin S; Billington CJ; Lee WJ; Bantle JP; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Sarr MG; Jensen MD; Vella A; Ahmed L; Belani K; Schone JL; Olofson AE; Bainbridge HA; Laqua PS; Wang Q; Korner J
Lancet Diabetes Endocrinol; 2015 Jun; 3(6):413-422. PubMed ID: 25979364
[TBL] [Abstract][Full Text] [Related]
5. Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial.
Hofsø D; Fatima F; Borgeraas H; Birkeland KI; Gulseth HL; Hertel JK; Johnson LK; Lindberg M; Nordstrand N; Cvancarova Småstuen M; Stefanovski D; Svanevik M; Gretland Valderhaug T; Sandbu R; Hjelmesæth J
Lancet Diabetes Endocrinol; 2019 Dec; 7(12):912-924. PubMed ID: 31678062
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg); a single-centre, randomised controlled trial.
Svanevik M; Lorentzen J; Borgeraas H; Sandbu R; Seip B; Medhus AW; Hertel JK; Kolotkin RL; Småstuen MC; Hofsø D; Hjelmesæth J
Lancet Diabetes Endocrinol; 2023 Aug; 11(8):555-566. PubMed ID: 37414071
[TBL] [Abstract][Full Text] [Related]
7. Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial.
Verrastro O; Panunzi S; Castagneto-Gissey L; De Gaetano A; Lembo E; Capristo E; Guidone C; Angelini G; Pennestrì F; Sessa L; Vecchio FM; Riccardi L; Zocco MA; Boskoski I; Casella-Mariolo JR; Marini P; Pompili M; Casella G; Fiori E; Rubino F; Bornstein SR; Raffaelli M; Mingrone G
Lancet; 2023 May; 401(10390):1786-1797. PubMed ID: 37088093
[TBL] [Abstract][Full Text] [Related]
8. Surgery for weight loss in adults.
Colquitt JL; Pickett K; Loveman E; Frampton GK
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003641. PubMed ID: 25105982
[TBL] [Abstract][Full Text] [Related]
9. Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Yan Y; Sha Y; Yao G; Wang S; Kong F; Liu H; Zhang G; Zhang H; Hu C; Zhang X
Medicine (Baltimore); 2016 Apr; 95(17):e3462. PubMed ID: 27124041
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for type 2 diabetes remission (ORDER): protocol of a multicentre, randomised controlled, open-label, superiority trial.
Li M; Liu Y; Lee WJ; Shikora SA; Robert M; Wang W; Wong SKH; Kong Y; Tong DKH; Tan CH; Zeng N; Zhu S; Wang C; Zhang P; Gu Y; Bai R; Meng F; Mao Z; Zhao X; Wu L; Liu Y; Zhang S; Zhang P; Zhang Z
BMJ Open; 2022 Sep; 12(9):e062206. PubMed ID: 36175102
[TBL] [Abstract][Full Text] [Related]
11. High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion.
Bonaventura A; Liberale L; Carbone F; Scopinaro N; Camerini G; Papadia FS; Cordera R; Dallegri F; Adami GF; Montecucco F
Nutr Metab Cardiovasc Dis; 2017 May; 27(5):423-429. PubMed ID: 28284664
[TBL] [Abstract][Full Text] [Related]
12. Effect of Bariatric Surgery vs Medical Treatment on Type 2 Diabetes in Patients With Body Mass Index Lower Than 35: Five-Year Outcomes.
Hsu CC; Almulaifi A; Chen JC; Ser KH; Chen SC; Hsu KC; Lee YC; Lee WJ
JAMA Surg; 2015 Dec; 150(12):1117-24. PubMed ID: 26374954
[TBL] [Abstract][Full Text] [Related]
13. Medium to long-term outcomes of bariatric surgery in older adults with super obesity.
Elbahrawy A; Bougie A; Loiselle SE; Demyttenaere S; Court O; Andalib A
Surg Obes Relat Dis; 2018 Apr; 14(4):470-476. PubMed ID: 29249586
[TBL] [Abstract][Full Text] [Related]
14. Sleeve gastrectomy versus Roux-en-Y gastric bypass for type 2 diabetes and morbid obesity: double-blind randomised clinical trial protocol.
Murphy R; Evennett NJ; Clarke MG; Robinson SJ; Humphreys L; Jones B; Kim DD; Cutfield R; Plank LD; Hammodat H; Booth MW
BMJ Open; 2016 Jul; 6(7):e011416. PubMed ID: 27377635
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial.
Robert M; Espalieu P; Pelascini E; Caiazzo R; Sterkers A; Khamphommala L; Poghosyan T; Chevallier JM; Malherbe V; Chouillard E; Reche F; Torcivia A; Maucort-Boulch D; Bin-Dorel S; Langlois-Jacques C; Delaunay D; Pattou F; Disse E
Lancet; 2019 Mar; 393(10178):1299-1309. PubMed ID: 30851879
[TBL] [Abstract][Full Text] [Related]
16. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
Halperin F; Ding SA; Simonson DC; Panosian J; Goebel-Fabbri A; Wewalka M; Hamdy O; Abrahamson M; Clancy K; Foster K; Lautz D; Vernon A; Goldfine AB
JAMA Surg; 2014 Jul; 149(7):716-26. PubMed ID: 24899464
[TBL] [Abstract][Full Text] [Related]
17. Roux-en-Y gastric bypass versus best medical treatment for type 2 diabetes mellitus in adults with body mass index between 27 and 32 kg/m
Cheng A; Yeoh E; Moh A; Low S; Tan CH; Lam B; Sum CF; Subramaniam T; Lim SC
Diabetes Res Clin Pract; 2022 Jun; 188():109900. PubMed ID: 35513159
[TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Bariatric Surgeries in Patients with Type 2 Diabetes Mellitus and BMI ≥ 25 kg/m
Carmona MN; Santos-Sousa H; Lindeza L; Sousa-Pinto B; Nogueiro J; Pereira A; Carneiro S; Costa-Pinho A; Lima-da-Costa E; Preto J;
Obes Surg; 2021 Dec; 31(12):5312-5321. PubMed ID: 34611827
[TBL] [Abstract][Full Text] [Related]
19. Long-term impact of weight loss for people with overweight but not obesity, and with type 2 diabetes: 10-year outcomes of a randomized trial of gastric band surgery.
Qi QYD; Playfair J; Brown WA; Burton P; O'Brien PE; Wentworth JM
Diabetes Obes Metab; 2023 Jun; 25(6):1464-1472. PubMed ID: 36700392
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
